{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T19:27:12Z","timestamp":1785353232645,"version":"3.55.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-21421-8","type":"journal-article","created":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T14:47:49Z","timestamp":1761662869000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Improved genomic characterization of a clinically heterogeneous pediatric cohort with WGS vs. WES"],"prefix":"10.1038","volume":"15","author":[{"given":"Awtum M.","family":"Brashear","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anxhela G.","family":"Gustafson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Quitadamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Evangelista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daelyn","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel P.","family":"Strom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly L.","family":"Snyder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Longoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamran","family":"Shazand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,28]]},"reference":[{"key":"21421_CR1","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s13073-023-01240-0","volume":"15","author":"AT Pagnamenta","year":"2023","unstructured":"Pagnamenta, A. T. et al. Structural and non-coding variants increase the diagnostic yield of clinical whole genome sequencing for rare diseases. Genome Med. 15, 94. https:\/\/doi.org\/10.1186\/s13073-023-01240-0 (2023).","journal-title":"Genome Med."},{"key":"21421_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-018-0087-0","volume":"50","author":"BS Gloss","year":"2018","unstructured":"Gloss, B. S. & Dinger, M. E. Realizing the significance of noncoding functionality in clinical genomics. Exp. Mol. Med. 50, 1\u20138. https:\/\/doi.org\/10.1038\/s12276-018-0087-0 (2018).","journal-title":"Exp. Mol. Med."},{"key":"21421_CR3","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/gim.2017.119","volume":"20","author":"AC Lionel","year":"2018","unstructured":"Lionel, A. C. et al. Improved diagnostic yield compared with targeted gene sequencing panels suggests a role for whole-genome sequencing as a first-tier genetic test. Genet. Med. 20, 435\u2013443. https:\/\/doi.org\/10.1038\/gim.2017.119 (2018).","journal-title":"Genet. Med."},{"key":"21421_CR4","doi-asserted-by":"publisher","first-page":"100880","DOI":"10.1016\/j.gim.2023.100880","volume":"25","author":"NS Abul-Husn","year":"2023","unstructured":"Abul-Husn, N. S. et al. Molecular diagnostic yield of genome sequencing versus targeted gene panel testing in Racially and ethnically diverse pediatric patients. Genet. Sci. 25, 100880. https:\/\/doi.org\/10.1016\/j.gim.2023.100880 (2023).","journal-title":"Genet. Sci."},{"key":"21421_CR5","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1001\/jamapediatrics.2021.3496","volume":"175","author":"NIS Group","year":"2021","unstructured":"Group, N. I. S. et al. Effect of Whole-Genome sequencing on the clinical management of acutely ill infants with suspected genetic disease: A randomized clinical trial. JAMA Pediatr. 175, 1218\u20131226. https:\/\/doi.org\/10.1001\/jamapediatrics.2021.3496 (2021).","journal-title":"JAMA Pediatr."},{"key":"21421_CR6","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1038\/s41431-022-01162-2","volume":"30","author":"LJ Ewans","year":"2022","unstructured":"Ewans, L. J. et al. Whole exome and genome sequencing in Mendelian disorders: a diagnostic and health economic analysis. Eur. J. Hum. Genet. 30, 1121\u20131131. https:\/\/doi.org\/10.1038\/s41431-022-01162-2 (2022).","journal-title":"Eur. J. Hum. Genet."},{"key":"21421_CR7","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13073-019-0675-1","volume":"11","author":"A Lindstrand","year":"2019","unstructured":"Lindstrand, A. et al. From cytogenetics to cytogenomics: whole-genome sequencing as a first-line test comprehensively captures the diverse spectrum of disease-causing genetic variation underlying intellectual disability. Genome Med. 11, 68. https:\/\/doi.org\/10.1186\/s13073-019-0675-1 (2019).","journal-title":"Genome Med."},{"key":"21421_CR8","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1038\/s41436-021-01242-6","volume":"23","author":"K Manickam","year":"2021","unstructured":"Manickam, K. et al. Exome and genome sequencing for pediatric patients with congenital anomalies or intellectual disability: an evidence-based clinical guideline of the American college of medical genetics and genomics (ACMG). Genet. Med. 23, 2029\u20132037. https:\/\/doi.org\/10.1038\/s41436-021-01242-6 (2021).","journal-title":"Genet. Med."},{"key":"21421_CR9","doi-asserted-by":"publisher","unstructured":"Clinical Genetics Group Of Medical Genetics Branch Chinese, Medical, A., Professional Committee For Prenatal Diagnosis Of Genetic Diseases Medical Genetics Branch Of Chinese Medical, Disease, A. G. O. G. & Birth Defect, P. C. [Expert consensus on the application of low-depth whole genome sequencing in prenatal diagnosis]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 36, 293\u2013296. https:\/\/doi.org\/10.3760\/cma.j.issn.1003-9406.2019.04.001 (2019). Control Committee Of Chinese Society Of Preventive.","DOI":"10.3760\/cma.j.issn.1003-9406.2019.04.001"},{"key":"21421_CR10","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1038\/s41431-022-01113-x","volume":"30","author":"E Souche","year":"2022","unstructured":"Souche, E. et al. Recommendations for whole genome sequencing in diagnostics for rare diseases. Eur. J. Hum. Genet. 30, 1017\u20131021. https:\/\/doi.org\/10.1038\/s41431-022-01113-x (2022).","journal-title":"Eur. J. Hum. Genet."},{"key":"21421_CR11","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1002\/jgc4.1646","volume":"32","author":"L Smith","year":"2023","unstructured":"Smith, L. et al. Genetic testing and counseling for the unexplained epilepsies: an evidence-based practice guideline of the National society of genetic counselors. J. Genet. Couns. 32, 266\u2013280. https:\/\/doi.org\/10.1002\/jgc4.1646 (2023).","journal-title":"J. Genet. Couns."},{"key":"21421_CR12","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41586-020-2434-2","volume":"583","author":"E Turro","year":"2020","unstructured":"Turro, E. et al. Whole-genome sequencing of patients with rare diseases in a National health system. Nature 583, 96\u2013102. https:\/\/doi.org\/10.1038\/s41586-020-2434-2 (2020).","journal-title":"Nature"},{"key":"21421_CR13","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/j.ajhg.2021.05.008","volume":"108","author":"D Dimmock","year":"2021","unstructured":"Dimmock, D. et al. Project baby bear: rapid precision care incorporating rWGS in 5 California children\u2019s hospitals demonstrates improved clinical outcomes and reduced costs of care. Am. J. Hum. Genet. 108, 1231\u20131238. https:\/\/doi.org\/10.1016\/j.ajhg.2021.05.008 (2021).","journal-title":"Am. J. Hum. Genet."},{"key":"21421_CR14","doi-asserted-by":"publisher","unstructured":"Bagger, F. O. et al. Whole genome sequencing in clinical practice. BMC Med. Genom. 17 https:\/\/doi.org\/10.1186\/s12920-024-01795-w (2024).","DOI":"10.1186\/s12920-024-01795-w"},{"key":"21421_CR15","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ajhg.2018.11.014","volume":"104","author":"Z Stark","year":"2019","unstructured":"Stark, Z. et al. Integrating genomics into healthcare: A global responsibility. Am. J. Hum. Genet. 104, 13\u201320. https:\/\/doi.org\/10.1016\/j.ajhg.2018.11.014 (2019).","journal-title":"Am. J. Hum. Genet."},{"key":"21421_CR16","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.gim.2021.08.009","volume":"24","author":"KA Phillips","year":"2022","unstructured":"Phillips, K. A. et al. US private payers\u2019 perspectives on insurance coverage for genome sequencing versus exome sequencing: A study by the clinical sequencing Evidence-Generating research consortium (CSER). Genet. Med. 24, 238\u2013244. https:\/\/doi.org\/10.1016\/j.gim.2021.08.009 (2022).","journal-title":"Genet. Med."},{"key":"21421_CR17","doi-asserted-by":"publisher","unstructured":"Jobanputra, V. et al. Advancing access to genome sequencing for rare genetic disorders: recent progress and call to action. Npj Genomic Med. 9 https:\/\/doi.org\/10.1038\/s41525-024-00410-2 (2024).","DOI":"10.1038\/s41525-024-00410-2"},{"key":"21421_CR18","doi-asserted-by":"publisher","unstructured":"Muurinen, M. et al. Mosaic deletions of known genes explain skeletal dysplasias with high and low bone mass. JBMR Plus. 6 https:\/\/doi.org\/10.1002\/jbm4.10660 (2022).","DOI":"10.1002\/jbm4.10660"},{"key":"21421_CR19","doi-asserted-by":"publisher","DOI":"10.1515\/almed-2025-0031","author":"N Bastida-Lertxundi","year":"2025","unstructured":"Bastida-Lertxundi, N. et al. Evaluating seven bioinformatics platforms for tertiary analysis of genomic data from whole exome sequencing in a pilot group of patients. Adv. Lab. Med. \/ Av. En Med. De Laboratorio. https:\/\/doi.org\/10.1515\/almed-2025-0031 (2025).","journal-title":"Adv. Lab. Med. \/ Av. En Med. De Laboratorio"},{"key":"21421_CR20","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s12920-022-01272-2","volume":"15","author":"S De Salvatore","year":"2022","unstructured":"De Salvatore, S. et al. Exploring the association between specific genes and the onset of idiopathic scoliosis: a systematic review. BMC Med. Genomics. 15, 115. https:\/\/doi.org\/10.1186\/s12920-022-01272-2 (2022).","journal-title":"BMC Med. Genomics"},{"key":"21421_CR21","doi-asserted-by":"publisher","unstructured":"Kotwicki, T. et al. Estrogen receptor type 1 and type 2 presence in paravertebral skeletal muscles: expression level and relation to phenotype in children with idiopathic scoliosis. Genes (Basel). https:\/\/doi.org\/10.3390\/genes13050739 (2022).","DOI":"10.3390\/genes13050739"},{"key":"21421_CR22","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1177\/21925682211066824","volume":"12","author":"KKL Lau","year":"2022","unstructured":"Lau, K. K. L. et al. Timely revisit of proprioceptive deficits in adolescent idiopathic scoliosis: A systematic review and Meta-Analysis. Global Spine J. 12, 1852\u20131861. https:\/\/doi.org\/10.1177\/21925682211066824 (2022).","journal-title":"Global Spine J."},{"key":"21421_CR23","doi-asserted-by":"crossref","unstructured":"Batista, R. M. B. F. et al. Association between vitamin d levels and adolescent idiopathic scoliosis. Coluna\/Columna 13 (2014).","DOI":"10.1590\/S1808-18512014130400432"},{"key":"21421_CR24","doi-asserted-by":"publisher","first-page":"e70271","DOI":"10.1111\/hex.70271","volume":"28","author":"H Osman","year":"2025","unstructured":"Osman, H. et al. From doubt to diagnosis: Canadian patient perspectives on a Limb-Girdle muscular dystrophy diagnosis. Health Expect. 28, e70271. https:\/\/doi.org\/10.1111\/hex.70271 (2025).","journal-title":"Health Expect."},{"key":"21421_CR25","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41572-021-00248-3","volume":"7","author":"D Duan","year":"2021","unstructured":"Duan, D., Goemans, N., Takeda, S., Mercuri, E. & Aartsma-Rus, A. Duchenne muscular dystrophy. Nat. Rev. Dis.Primers. 7, 13. https:\/\/doi.org\/10.1038\/s41572-021-00248-3 (2021).","journal-title":"Nat. Reviews Disease Primers"},{"key":"21421_CR26","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1001\/jamaneurol.2015.3537","volume":"73","author":"MA Gatheridge","year":"2016","unstructured":"Gatheridge, M. A. et al. Identifying Non\u2013Duchenne muscular dystrophy\u2013Positive and false negative results in prior Duchenne muscular dystrophy newborn screening programs: A review. JAMA Neurol. 73, 111\u2013116. https:\/\/doi.org\/10.1001\/jamaneurol.2015.3537 (2016).","journal-title":"JAMA Neurol."},{"key":"21421_CR27","doi-asserted-by":"crossref","unstructured":"Pedersen, B. S. & Quinlan, A. R. Who\u2019s Who? Detecting and resolving sample anomalies in human DNA sequencing studies with Peddy. Am. J. Hum. Genet. 100, 406\u2013413  (2017).","DOI":"10.1016\/j.ajhg.2017.01.017"},{"key":"21421_CR28","doi-asserted-by":"crossref","unstructured":"Garg, B., Tomar, N., Biswas, A., Mehta, N. & Malhotra, R. Understanding musculoskeletal disorders through Next-Generation sequencing. JBJS Reviews 10 (2022).","DOI":"10.2106\/JBJS.RVW.21.00165"},{"key":"21421_CR29","doi-asserted-by":"publisher","first-page":"100896","DOI":"10.1016\/j.gim.2023.100896","volume":"25","author":"CCY Chung","year":"2023","unstructured":"Chung, C. C. Y. et al. Meta-analysis of the diagnostic and clinical utility of exome and genome sequencing in pediatric and adult patients with rare diseases across diverse populations. Genet. Sci. 25, 100896. https:\/\/doi.org\/10.1016\/j.gim.2023.100896 (2023).","journal-title":"Genet. Sci."},{"key":"21421_CR30","doi-asserted-by":"publisher","first-page":"e412","DOI":"10.1212\/NXG.0000000000000412","volume":"6","author":"TL Winder","year":"2020","unstructured":"Winder, T. L. et al. Clinical utility of multigene analysis in over 25,000 patients with neuromuscular disorders. Neurol. Genet. 6, e412. https:\/\/doi.org\/10.1212\/NXG.0000000000000412 (2020).","journal-title":"Neurol. Genet."},{"key":"21421_CR31","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/s41431-023-01312-0","volume":"31","author":"M Pennings","year":"2023","unstructured":"Pennings, M. et al. Copy number variants from 4800 exomes contribute to ~\u20097% of genetic diagnoses in movement disorders, muscle disorders and neuropathies. Eur. J. Hum. Genet. 31, 654\u2013662. https:\/\/doi.org\/10.1038\/s41431-023-01312-0 (2023).","journal-title":"Eur. J. Hum. Genet."},{"key":"21421_CR32","doi-asserted-by":"publisher","unstructured":"Yang, M. et al. Diagnostic utility of whole genome sequencing after negative karyotyping\/chromosomal microarray in infants born with multiple congenital anomalies. jkms 39, e250-250.  https:\/\/doi.org\/10.3346\/jkms.2024.39.e250  (2024).","DOI":"10.3346\/jkms.2024.39.e250"},{"key":"21421_CR33","doi-asserted-by":"publisher","unstructured":"Gao, Y. et al. Whole-Genome sequencing is a viable replacement for chromosomal microarray and fragile X PCR Testing. medRxiv. https:\/\/doi.org\/10.1101\/2025.05.24.25328260 (2025).","DOI":"10.1101\/2025.05.24.25328260"},{"key":"21421_CR34","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/s41586-020-2287-8","volume":"581","author":"RL Collins","year":"2020","unstructured":"Collins, R. L. et al. A structural variation reference for medical and population genetics. Nature 581, 444\u2013451. https:\/\/doi.org\/10.1038\/s41586-020-2287-8 (2020).","journal-title":"Nature"},{"key":"21421_CR35","doi-asserted-by":"publisher","unstructured":"Akgun-Dogan, O. et al. Impact of deep phenotyping: high diagnostic yield in a diverse pediatric population of 172 patients through clinical whole-genome sequencing at a single center. Front. Genet. 15 https:\/\/doi.org\/10.3389\/fgene.2024.1347474 (2024).","DOI":"10.3389\/fgene.2024.1347474"},{"key":"21421_CR36","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1002\/ana.24650","volume":"79","author":"A Vanderver","year":"2016","unstructured":"Vanderver, A. et al. Whole exome sequencing in patients with white matter abnormalities. Ann. Neurol. 79, 1031\u20131037. https:\/\/doi.org\/10.1002\/ana.24650 (2016).","journal-title":"Ann. Neurol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-21421-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-21421-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-21421-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T02:03:48Z","timestamp":1762049028000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-21421-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,28]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["21421"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-21421-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,28]]},"assertion":[{"value":"22 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"ML, HLS, and SPS are employed by Illumina, Inc. The authors report no other competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Informed consent and patient assent were obtained from participants and their parent(s) or legally authorized representative(s) as applicable in person or through a virtual process conducted by SHC staff authorized to obtain consent for this study. The sample collection performed was approved by WCG Institutional Review Board, protocol number 2019150. All methods were carried out in accordance with the ethical principles in the Declaration of Helsinki and the Belmont Report. The post-processing comparison of WES and WGS data was undertaken as a Quality Improvement Initiative at Shriners Hospitals for Children and, as such, was not formally supervised by an Institutional Review Board.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent and patient assent were obtained from participants and their parent(s) or legally authorized representative(s) as applicable and conducted by SHC staff authorized to obtain consent for this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"37679"}}